17 patents
Utility
Extended-release Pharmaceutical Compositions for Treating Eye Conditions
7 Sep 23
The present disclosure encompasses methods and compositions for extended-release formulations for treating ophthalmic conditions.
Dennis E. Saadeh, Mark L. Baum, Richard L. Lindstrom
Filed: 7 Mar 22
Utility
Ophthalmic Dye Composition and Method for Administering Same
7 Sep 23
The present disclosure encompasses methods and compositions for staining ocular structures in ophthalmologic procedures.
Dennis Saadeh, William Wiley, Mark Baum
Filed: 3 Mar 23
Utility
Methods for Increasing Shelf-life of Ophthalmic Pharmaceutical Compositions
16 Feb 23
The present disclosure relates to methods for extending the shelf life of a sterile ophthalmic pharmaceutical composition.
Ernesto Fernandez, William F. Wiley
Filed: 4 Aug 22
Utility
Methods and System for Remotely Capturing Media Via a User Interface Bidirectionally Linked to a Remote Server
24 Nov 22
Some embodiments of the present disclosure present methods and systems for remotely capturing an image of an eye of a user via a user interface bidirectionally linked to a remote server that is configured to anonymize data communicated from the user device.
Mark L. Baum, Andrew E. Livingston, Ryan Kibler
Filed: 18 May 22
Utility
Methods and System for Measuring Interaction Between a User Interface and Remote Server
31 Mar 22
Some embodiments of the present disclosure present methods and systems for measuring an interaction level between a user interface and a remote server and charges for the interaction.
Mark L. BAUM, Eric Hendrickson, Andrew E. Livingston, Garrett Scarborough
Filed: 22 Sep 21
Utility
Systems and Methods for Automated Intake of Patient Data
23 Dec 21
Some embodiments of the present disclosure disclose methods and systems for automated intake of patient data, and more specifically, for generating structured database of patients and real-time identification of health care providers for the patients based on the received real-time patient data.
Mark L. BAUM, Andrew E. LIVINGSTON
Filed: 22 Jun 21
Utility
Systems and Methods for Transacting Prescriptions Using a Mobile Device
23 Dec 21
Some embodiments of the present disclosure disclose methods and systems for issuing and filling medical prescriptions for a patient.
Mark L. BAUM, Andrew E. Livingston, Feliks Dushatsky
Filed: 22 Jun 21
Utility
Epinephrine-based Ophthalmic Compositions for Intraocular Administration and Methods for Fabricating Thereof
11 Nov 21
Pharmaceutical compositions for intraocular injection are described, the compositions comprise therapeutically effective quantity of lyophilized preservative-free and sulfite-free epinephrine or adrenaline and a metal chelator.
John Scott Karolchyk, Mark L. Baum, Dennis Saadeh
Filed: 23 Jul 21
Utility
Epinephrine-based Ophthalmic Compositions for Intraocular Administration and Methods for Fabricating Thereof
9 Sep 21
Pharmaceutical compositions for intraocular injection are described, the compositions comprise therapeutically effective quantity of lyophilized preservative-free and sulfite-free epinephrine or adrenaline and a metal chelator.
John Scott Karolchyk, Mark L. Baum
Filed: 25 May 21
Utility
Pharmaceutical Compositions Comprising Heparinoids and Methods for Preparing Thereof
11 Mar 21
Pharmaceutical compositions are described herein, among others, the compositions comprising anhydrous suspensions of a therapeutically effective quantity of a heparinoid, or a derivative or analog thereof, and to methods of preparing and using such compositions.
Dennis Elias Saadeh
Filed: 1 Sep 20
Utility
Pharmaceutical Compositions for Treating Presbyopia and Methods for Fabricating Thereof
11 Nov 20
Pharmaceutical compositions for treating presbyopia are described, the compositions comprising choline esterase inhibitor(s) and several other components such as α-1-adrenergic antagonist(s), non-steroid anti-inflammatory drug(s), and/or adrenergic antagonist(s).
Dennis Elias Saadeh
Filed: 23 Apr 20
Utility
Pharmaceutical Formulations for the Treatment of Dry Eye and Methods for Fabricating and Using Thereof
26 Aug 20
Methods and kits for improving tear production are described, along with topical pharmaceutical compositions.
John Scott Karolchyk, John P. Saharek
Filed: 10 May 20
Utility
Pyrimethamine-based Pharmaceutical Compositions and Methods for Fabricating Thereof
5 Aug 20
Pharmaceutical compositions that include aqueous suspensions of therapeutically effective quantity of a diaminopyrimidine compound (such as pyrimethamine) are provided herein.
Dennis Elias Saadeh
Filed: 19 Apr 20
Utility
Pharmaceutical Compositions Comprising Gels and Methods for Fabricating Thereof
20 May 20
Pharmaceutical compositions are described, the compositions comprising a therapeutically effective quantity of an active component and a quantity of a sterile gel.
John Scott Karolchyk, Dennis Elias Saadeh
Filed: 26 Jan 20
Utility
Adrenocorticotropic Hormone-based Pharmaceutical Formulations and Methods for Fabricating and Using Thereof
20 May 20
Pharmaceutical compositions for treating, mitigating or preventing autoimmune diseases and associated conditions are described herein.
Dennis Elias Saadeh, Mark L. Baum
Filed: 27 Jan 20
Utility
Pharmaceutical Compositions for Prevention or Treatment of Cytokine Release Syndrome
1 Apr 20
Pharmaceutical compositions and methods for preventing, treating, or alleviating cytokine release syndrome are described, the compositions comprising pentoxifylline and a pharmaceutically acceptable carrier.
Annette Marleau, Thomas Ichim, Dennis Elias Saadeh
Filed: 24 Sep 19
Utility
Pyrimethamine-based Pharmaceutical Compositions and Methods for Fabricating Thereof
11 Dec 19
Pharmaceutical compositions that include aqueous suspensions of a therapeutically effective quantity of a diaminopyrimidine compound (such as pyrimethamine) are provided herein.
Dennis Elias Saadeh, Annette Marleau, Thomas Ichim
Filed: 5 Jun 19
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first